Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,354 | -18,741 | -10,866 | -3,790 | 986 |
| Depreciation Amortization | 923 | 3,292 | 2,368 | 1,458 | 677 |
| Accounts receivable | 4,794 | 2,454 | -4,931 | -1,602 | -3,776 |
| Accounts payable and accrued liabilities | -2,234 | -779 | 1,026 | 485 | 523 |
| Other Working Capital | 4,211 | -238 | -5,074 | -3,528 | -4,235 |
| Other Operating Activity | -1,946 | -9,448 | -4,427 | -7,010 | -3,713 |
| Operating Cash Flow | $-1,606 | $-23,460 | $-21,905 | $-13,986 | $-9,538 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -2,090 | -1,972 | -1,894 | -1,281 |
| Investing Cash Flow | $-21 | $-2,090 | $-1,972 | $-1,894 | $-1,281 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,236 | N/A | N/A | N/A |
| Debt Repayment | -34 | -161 | -120 | -88 | -805 |
| Common Stock Issued | 2 | 7,758 | 77 | 77 | 8 |
| Other Financing Activity | -328 | -7,781 | -7,293 | -7,038 | -5,521 |
| Financing Cash Flow | $-360 | $1,051 | $-7,336 | $-7,049 | $-6,318 |
| Beginning Cash Position | 15,047 | 39,545 | 39,545 | 39,545 | 39,545 |
| End Cash Position | 13,060 | 15,047 | 8,332 | 16,617 | 22,408 |
| Net Cash Flow | $-1,987 | $-24,498 | $-31,213 | $-22,929 | $-17,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,606 | -23,460 | -21,905 | -13,986 | -9,538 |
| Capital Expenditure | -21 | -2,166 | -2,049 | -1,970 | -1,357 |
| Free Cash Flow | -1,627 | -25,626 | -23,953 | -15,956 | -10,895 |